Cargando…
A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer
BACKGROUND: While the efficacy of immune checkpoint inhibitors (ICIs) is increasingly recognized in advanced gastric cancer (aGC), overall survival (OS) has not been consistently improved across the different randomized controlled trials (RCTs). This meta-analysis aimed to quantify the efficacy and...
Autores principales: | El Helali, Aya, Tao, Jun, Wong, Charlene H. L., Chan, Wendy Wing-Lok, Mok, Ka-Chun, Wu, Wing Fong, Shitara, Kohei, Mohler, Markus, Boku, Narikazu, Pang, Herbert, Lam, Ka On |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660259/ https://www.ncbi.nlm.nih.gov/pubmed/36387109 http://dx.doi.org/10.3389/fonc.2022.908026 |
Ejemplares similares
-
HER2-positive gastric cancer
por: Boku, Narikazu
Publicado: (2013) -
Third-line systemic treatment in advanced/metastatic gastric cancer:
a comprehensive review
por: Chan, Wing-lok, et al.
Publicado: (2019) -
Brain Microstructural Changes Associated With Neurocognitive Outcome in Intracranial Germ Cell Tumor Survivors
por: Tso, Winnie Wan Yee, et al.
Publicado: (2021) -
Case report: Irinotecan-induced interstitial lung disease in an advanced colorectal cancer patient resurfacing decades after allogeneic bone marrow transplantation for aplastic anemia; a case report and narrative review of literature
por: Baba, Keisuke, et al.
Publicado: (2023) -
Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
por: Cheung, Ka Shing, et al.
Publicado: (2022)